Press Releases

Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced the publication of positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR). These results demonstrate the durable treatment effect of RhinAer® for treating chronic rhinitis, showing a significa

VeriNew is poised to disrupt the healthcare landscape by offering tailored care plans and direct-to-patient prescription services, thereby setting a new standard in healthcare delivery. Departing from traditional models, VeriNew takes a proactive approach to combating the stigma often associated with seeking medical assistance. Central to its mission is the provision of personalized 1:1 coaching sessions led by expert practitioners specializing in various areas, including weight loss, sexual

Empatica, a leader in remote health monitoring powered by AI, is proud to announce the official launch of EpiMonitor, the latest advancement in wearable epilepsy monitoring. EpiMonitor has been FDA-cleared for use in adult and children populations aged 6 and up, and is the only wearable solution with regulatory approval for seizure detection available to purchase in the US. It is the successor to Embrace2, which enjoyed global acclaim as the leading wearable for seizu

We are excited to introduce the 1st Healthcare Innovation & Transformation Summit, taking place in May 20-21 at the Four Seasons Hotel in Westlake Village, CA, USA. The Healthcare Innovation & Transformation Summit is an invitation-only, premium Summit bringing leading senior level healthcare executives and innovative suppliers and solution providers together. The Healthcare Innovation & Transformation Summit provides a platform that helps America’s seni

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced ProSense® was featured in a number of sessions, including one titled "Minimal access imaging guided therapies: cryoablative therapies in breast pathologies," at the fourth Breast Imaging & Interventio

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, has announced that the Company is progressing towards 510(k) clearance from the U.S. Food & Drug Administration ("FDA") for its INSPIRA™ ART100 in the first half of 2024. The Company plans additional FDA 510(k) submissions for the HYLA blood sensor in 2024 and for INSPIRA ART disposabl

We are excited to introduce the 1st Healthcare Patient Experience & Engagement Summit, taking place in May 20-21 at the Four Seasons Hotel in Westlake Village, CA, USA. The Healthcare Patient Experience & Engagement Summit is an invitation-only, premium Summit bringing leading senior level healthcare executives and innovative suppliers and solution providers together. The Healthcare Patient Experience & Engagement Summit provides a platform that helps America&

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its collaboration with the Saint-Louis Hospital AP-HP in Paris on an airflow simulation and augmented reality experience to better understand the respiratory transmission of viruses and optimize patient care. Dassault Systèmes created a unique learning experience featuring a virtual twin of the hospital’s dialysis unit – an open space where 50 people receive dialysis each week &nd

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced new data from a preliminary, independent breast cancer study conducted by Principal Investigator and ProSense® user, Dr. Federica. di Naro, of Azienda Ospedaliero-Universitaria Careggi, Diagnostic Senology Unit in 

Curai Health, a virtual clinic, announced that it is expanding access to high-quality care for individuals experiencing homelessness. In collaboration with Healthcare in Action, a street-based medical group that provides comprehensive healthcare services for behavioral health and substance use disorders, as well as housing navigation and care management support for individuals experiencing homelessness, Curai’s platform will support in delivering convenient virtual care to patients